CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,108 | 20,250 | ||
| 2022-02-15 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −388 | $44.01 | $17K | 19,862 |
| 2022-02-15 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −1,108 | 1,108 | ||
| 2022-02-15 | Pierce David A EVP Pres MedSurg | Exercise or conversion | +2,769 | 2,769 | ||
| 2022-02-15 | Pierce David A EVP Pres MedSurg | Shares withheld for taxes | −813 | $44.01 | $36K | 1,956 |
| 2022-02-15 | Pierce David A EVP Pres MedSurg | Exercise or conversion · Deferred Stock Units | −2,769 | 2,769 | ||
| 2022-02-15 | Olson Scott SVP & Pres, CRM, Diagnostics | Exercise or conversion | +1,292 | 13,551 | ||
| 2022-02-15 | Olson Scott SVP & Pres, CRM, Diagnostics | Shares withheld for taxes | −707 | $44.01 | $31K | 12,844 |
| 2022-02-15 | Olson Scott SVP & Pres, CRM, Diagnostics | Exercise or conversion · Deferred Stock Units | −1,292 | 1,292 | ||
| 2022-02-15 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion | +1,661 | 173,067 | ||
| 2022-02-15 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −575 | $44.01 | $25K | 172,492 |
| 2022-02-15 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Deferred Stock Units | −1,661 | 1,661 | ||
| 2022-02-15 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +738 | 29,481 | ||
| 2022-02-15 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −259 | $44.01 | $11K | 29,222 |
| 2022-02-15 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Deferred Stock Units | −738 | 739 | ||
| 2022-02-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +2,030 | 135,183 | ||
| 2022-02-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −622 | $44.01 | $27K | 134,561 |
| 2022-02-15 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Deferred Stock Units | −2,030 | 2,031 | ||
| 2022-02-15 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,108 | 31,947 | ||
| 2022-02-15 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −326 | $44.01 | $14K | 31,621 |
Page 82 of 87 · 1,736 trades